The Interaction of CORM-2 with Block Copolymers Containing Poly(4-vinylpyridine): Macromolecular Scaffolds for Carbon Monoxide Delivery in Biological Systems

CO-Releasing Polymers Exert Antimicrobial Activity

(2015) Diep Nguyen et al.   BIOMACROMOLECULES

CO-releasing Metal Carbonyl Compounds as Antimicrobial Agents in the Post-antibiotic Era

(2015) Lauren K. Wareham et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Origami with ABC Triblock Terpolymers Based on Glycopolymers: Creation of Virus-Like Morphologies

(2015) Aydan Dag et al.   ACS Macro Letters

Self-powered electrochemical memristor based on a biofuel cell – towards memristors integrated with biocomputing systems

(2014) Kevin MacVittie et al.   CHEMICAL COMMUNICATIONS

Development of next-generation macromolecular drugs based on the EPR effect: challenges and pitfalls

(2014) Hideaki Nakamura et al.   Expert Opinion on Drug Delivery

Styrene-maleic acid copolymer-encapsulated CORM2, a water-soluble carbon monoxide (CO) donor with a constant CO-releasing property, exhibits therapeutic potential for inflammatory bowel disease

(2014) Hongzhuan Yin et al.   JOURNAL OF CONTROLLED RELEASE

Control of Morphology and Corona Composition in Aggregates of Mixtures of PS-b-PAA and PS-b-P4VP Diblock Copolymers: Effects of Solvent, Water Content, and Mixture Composition

(2014) Renata Vyhnalkova et al.   LANGMUIR

Synthesis, Spectroscopic Properties, and Photoinduced CO-Release Studies of Functionalized Ruthenium(II) Polypyridyl Complexes: Versatile Building Blocks for Development of CORM–Peptide Nucleic Acid Bioconjugates

(2013) Caroline Bischof et al.   INORGANIC CHEMISTRY

The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo

(2012) Hiroshi Maeda et al.   ADVANCED DRUG DELIVERY REVIEWS

Carbon Monoxide Reduces Neuropathic Pain and Spinal Microglial Activation by Inhibiting Nitric Oxide Synthesis in Mice

(2012) Arnau Hervera et al.   PLoS One

Differential Antibacterial Activity Against Pseudomonas aeruginosa by Carbon Monoxide-Releasing Molecules

(2011) Mathieu Desmard et al.   ANTIOXIDANTS & REDOX SIGNALING

Ex vivoApplication of Carbon Monoxide in UW Solution Prevents Transplant-Induced Renal Ischemia/Reperfusion Injury in Pigs

(2010) J. Yoshida et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Carbon Monoxide-Releasing Micelles for Immunotherapy

(2010) Urara Hasegawa et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

The therapeutic potential of carbon monoxide

(2010) Roberto Motterlini et al.   NATURE REVIEWS DRUG DISCOVERY

Polymers for Drug Delivery Systems

(2010) William B. Liechty et al.   Annual Review of Chemical and Biomolecular Engineering

Carbon Monoxide Liberated from CO-Releasing Molecule (CORM-2) Attenuates Ischemia/Reperfusion (I/R)-Induced Inflammation in the Small Intestine

(2009) Kazuhiro Katada et al.   INFLAMMATION

Exploring the antimicrobial action of a carbon monoxide-releasing compound through whole-genome transcription profiling of Escherichia coli

(2009) L. S. Nobre et al.   MICROBIOLOGY-SGM

The CO-releasing molecule CORM-2 is a novel regulator of the inflammatory process in osteoarthritic chondrocytes

(2008) M. I. Guillen et al.   RHEUMATOLOGY

Carbon monoxide liberated from carbon monoxide-releasing molecule CORM-2 attenuates inflammation in the liver of septic mice

(2007) Gediminas Cepinskas et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

The carbon monoxide-releasing molecule CORM-2 inhibits the inflammatory response induced by cytokines in Caco-2 cells

(2007) J Megías et al.   BRITISH JOURNAL OF PHARMACOLOGY